Xeljanz
List of products in the National Drug Code with proprietary name xeljanz. Tofacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, polyarticular course juvenile idiopathic arthritis-pcJIA). It helps to decrease pain/tenderness/swelling in the joints. Tofacitinib is also used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
0069-0501 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-0502 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1001 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1002 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1029 | Xeljanz | Tofacitinib | Solution | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
63539-012 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | Human Prescription Drug |
63539-016 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | Human Prescription Drug |
63539-501 | Xeljanz XR | Tofacitinib | Tablet, Extended Release | Oral | U.s. Pharmaceuticals | Human Prescription Drug |
63539-502 | Xeljanz XR | Tofacitinib | Tablet, Extended Release | Oral | U.s. Pharmaceuticals | Human Prescription Drug |